A detailed history of Stonegate Investment Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Stonegate Investment Group, LLC holds 33,657 shares of ABBV stock, worth $6.06 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
33,657
Previous 32,800 2.61%
Holding current value
$6.06 Million
Previous $5.63 Million 18.15%
% of portfolio
0.18%
Previous 0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$163.84 - $199.33 $140,410 - $170,825
857 Added 2.61%
33,657 $6.65 Million
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $260,356 - $304,038
1,682 Added 5.41%
32,800 $5.63 Million
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $57.3 Million - $65.3 Million
-358,321 Reduced 92.01%
31,118 $5.67 Million
Q4 2023

Jan 23, 2024

BUY
$137.6 - $154.97 $3,027 - $3,409
22 Added 0.01%
389,439 $60.4 Million
Q3 2023

Oct 24, 2023

SELL
$133.59 - $154.65 $27,920 - $32,321
-209 Reduced 0.05%
389,417 $58 Million
Q2 2023

Jul 26, 2023

BUY
$132.51 - $164.9 $85,866 - $106,855
648 Added 0.17%
389,626 $52.5 Million
Q1 2023

Apr 20, 2023

BUY
$144.61 - $166.54 $1.55 Million - $1.78 Million
10,718 Added 2.83%
388,978 $62 Million
Q4 2022

Jan 24, 2023

SELL
$138.31 - $165.87 $111,754 - $134,022
-808 Reduced 0.21%
378,260 $0
Q3 2022

Oct 28, 2022

BUY
$134.21 - $153.93 $308,683 - $354,039
2,300 Added 0.61%
379,068 $50.9 Million
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $1.49 Million - $1.89 Million
10,815 Added 2.96%
376,768 $57.7 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $1.05 Million - $1.31 Million
7,973 Added 2.23%
365,953 $59.3 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $38.5 Million - $48.7 Million
357,980 New
357,980 $48.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Stonegate Investment Group, LLC Portfolio

Follow Stonegate Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonegate Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonegate Investment Group, LLC with notifications on news.